NVAX Stock Price Up 35% Now as Novavax Gets $1.6 Billion Grant for COVID-19 Vaccine Development
NVAX stock price is skyrocketing these days as Novavax is getting one step closer to the development of its coronavirus vaccine.
NVAX Stock Up 5.7% Now, Novavax CEO Says Coronavirus Workers Could Get Vaccine This Year
Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate. NVAX stock is up.
NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine Trials
Novavax (NVAX) has jumped by 16% in the pre-market. The company has announced human trials its COVID-19 vaccine.
Novavax (NVAX) Stock Jumped 6% Yesterday on $4M Funding for Coronavirus Vaccine Trial
By
Tolu Ajiboye
Novavax (NVAX) stock jumped again yesterday after it received a $4 million award to be pumped into developing a vaccine for COVID-19. However, today it is falling.